Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL

  1. Hochhaus, A.
  2. Réa, D.
  3. Boquimpani, C.
  4. Minami, Y.
  5. Cortes, J.E.
  6. Hughes, T.P.
  7. Apperley, J.F.
  8. Lomaia, E.
  9. Voloshin, S.
  10. Turkina, A.
  11. Kim, D.-W.
  12. Abdo, A.
  13. Fogliatto, L.M.
  14. le Coutre, P.
  15. Sasaki, K.
  16. Kim, D.D.H.
  17. Saussele, S.
  18. Annunziata, M.
  19. Chaudhri, N.
  20. Chee, L.
  21. García-Gutiérrez, V.
  22. Kapoor, S.
  23. Allepuz, A.
  24. Quenet, S.
  25. Bédoucha, V.
  26. Mauro, M.J.
  27. Erakutsi egile guztiak +
Aldizkaria:
Leukemia

ISSN: 1476-5551,  0887-6924

Argitalpen urtea: 2023

Alea: 37

Zenbakia: 3

Orrialdeak: 617-626

Mota: Artikulua

DOI: 10.1038/S41375-023-01829-9 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus